共 85 条
[41]
Barbier O., Torra I.P., Duguay Y., Et al., Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 22, pp. 717-726, (2002)
[42]
Duval C., Chinetti G., Trottein F., Et al., The role of PPARs in atherosclerosis, Trends Mol. Med., 8, pp. 422-430, (2002)
[43]
Fruchart J.C., Staels B., Duriez P., PPARS, metabolic disease and atherosclerosis, Pharmacol. Res., 44, pp. 345-352, (2001)
[44]
Vosper H., Khoudoli G.A., Graham T.L., Palmer CN: Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis, Pharmacol. Ther., 95, pp. 47-62, (2002)
[45]
Kersten S., Desvergne B., Wahli W., Roles of PPARs in health and disease, Nature, 405, pp. 421-424, (2000)
[46]
Escher P., Wahli W., Peroxisome proliferator-activated receptors: Insight into multiple cellular functions, Mutat. Res., 448, pp. 121-138, (2000)
[47]
Rocchi S., Auwerx J., Peroxisome proliferator-activated receptor-gamma: A versatile metabolic regulator, Ann. Med., 31, pp. 342-351, (1999)
[48]
Schoonjans K., Staels B., Auwerx J., The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation, Biochim. Biophys. Acta, 1302, pp. 93-109, (1996)
[49]
Tontonoz P., Hu E., Graves R.A., Et al., mPpar gamma 2: Tissue-specific regulator of an adipocyte enhancer, Genes Dev., 8, pp. 1224-1234, (1994)
[50]
Tontonoz P., Nagy L., Alvarez J.G., Et al., PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL, Cell, 93, pp. 241-252, (1998)